HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000017 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 9, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
44,248
Total Value
$0.00
P&L
+inf% (+$2,806,650.64)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SVP, CHIEF OPERATING OFFICER | Option to Purchase Common Stock | Derivative | Feb 9, 2026 | Grant/Award | 14,047 | $0.00 | $0.00 | 14,047 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Restricted Stock Units | Derivative | Feb 9, 2026 | Grant/Award | 13,047 | $0.00 | $0.00 | 13,047 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Performance Stock Units | Derivative | Feb 9, 2026 | Grant/Award | 2,403 | $0.00 | $0.00 | 13,886 | Direct | โ | View Details | |
SVP, CHIEF OPERATING OFFICER | Performance Stock Units | Derivative | Feb 9, 2026 | Grant/Award | 14,751 | $0.00 | $0.00 | 14,751 | Direct | โ | View Details |